Is there any therapeutic value for the use of histone deacetylase inhibitors for chronic pain?

Wei Wang, Shan shan Cui, Rui Lu, Hui Zhang

Research output: Contribution to journalReview articlepeer-review

11 Scopus citations

Abstract

Chronic pain is a complex clinical condition that reduces the quality of life for billions of people. In recent years, the role of epigenetic modulation in the control of long-term neuronal plasticity has attracted the attention of pain researchers. The epigenetic mechanisms include covalent modifications of DNA and/or histone proteins. Mounting evidence suggests that the activity of histone deacetylases (HDACs) and levels of histone acetylation are dynamic and that these enzymes modulate pain-related synaptic plasticity. Therefore, HDACs play essential roles in chronic pain development and maintenance. In this mini review, we will discuss the role of HDACs in the pathogenesis of chronic pain and will consider the therapeutic value of HDAC inhibitors in treating chronic pain.

Original languageEnglish (US)
Pages (from-to)44-52
Number of pages9
JournalBrain Research Bulletin
Volume125
DOIs
StatePublished - Jul 1 2016
Externally publishedYes

Keywords

  • Chronic pain
  • Epigenetic
  • Histone deacetylases
  • Inhibitors

ASJC Scopus subject areas

  • General Neuroscience

Fingerprint

Dive into the research topics of 'Is there any therapeutic value for the use of histone deacetylase inhibitors for chronic pain?'. Together they form a unique fingerprint.

Cite this